USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: LAMBDA PHARMACEUTICALS
City: LAS VEGAS
State: NV
Zip+4: 89134
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: (702) 255-2934

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $298,975.00 3
STTR Phase I $99,053.00 1

Award List:

COST EFFECTIVE PHOTOSENSITIZERS FOR USE IN PDT

Award Year / Program / Phase: 1997 / SBIR / Phase I
Agency: HHS
Principal Investigator: Morgan, alan r
Award Amount: $98,975.00
Abstract:
Photodynamic therapy has been approved for certain indications in the USA, Japan, Canada, France and Netherlands. The only drug approved, Photofrin, is not ideal and a significant research effort has led to the development of second generation sensitizers. Many of these agents are hydrophobic and… More

PHOTOFENTON REAGENTS AS PDT SENSITIZERS

Award Year / Program / Phase: 1998 / STTR / Phase I
Agency: HHS
Research Institution: University of Toledo
Principal Investigator: Morgan
Award Amount: $99,053.00
RI Contact: N/A

N/A

Award Year / Program / Phase: 2000 / SBIR / Phase I
Agency: HHS
Principal Investigator: Robert C. Hall
Award Amount: $100,000.00

Choroidal Neovascular Occlusion Using PDT

Award Year / Program / Phase: 2001 / SBIR / Phase I
Agency: HHS
Principal Investigator: Alan R. Morgan
Award Amount: $100,000.00
Abstract:
DESCRIPTION (From the Applicant's Abstract): Photodynamic therapy (PDT) is a new potential treatment of the subfoveal choroidal neovascularization (CNV) that may accompany age-related macular degeneration (AMD). PDT involves the use of a… More